In obese HFD-induced mice, kaempferol protected against obesity and ameliorated hyperlipidemia partly through maintaining microbial diversity and modulating microbial communities as well as downregulating PPARγ and SREBP-1C [58,59]. Here, PPARG is linked to obesity due to melanocortin 4 receptor deficiency.